GENEVA (Reuters) - Switzerland's drug regulator said on Tuesday it had approved the testing of an experimental Ebola vaccine from GlaxoSmithKline on healthy volunteers, some of whom will be traveling to West Africa as medical staff. The trial will be conducted among 120 volunteer participants at the Lausanne University Hospital, with support from the World Health Organization. The volunteers, who include many medical students, will be monitored for six months to determine both the safety and efficacy of the vaccine. ...
via Health News Headlines - Yahoo News http://ift.tt/1xzPuhR
No comments:
Post a Comment